Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gulmezoglu AM. Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. Journal of Maternal-Fetal and Neonatal Medicine. 2013;26(17):1705–1709. [PubMed: 23574458]

Abul-Azm A, Abdullah KM. Effect of topical tranexamic acid in open heart surgery. European Journal of Anaesthesiology. 2006;23(5):380–384. [PubMed: 16438759]

Abuzakuk T, Senthil K V, Shenava Y, Bulstrode C, Skinner JA, Cannon SR, et al. Autotransfusion drains in total knee replacement. Are they alternatives to homologous transfusion? International Orthopaedics. 2007;31(2):235–239. [PMC free article: PMC2267563] [PubMed: 16761149]

Aghdaii N, Kabiri M, Yazdanian F, Ghaffarinejad MH. Effect of retransfusion of heparin remaining in the salvaged blood on postoperative blood loss in coronary artery bypass grafting: Comparison with homologous blood transfusion (running title: Postoperative blood loss in CABG). Iranian Heart Journal. 2012;13(2):24–34.

Agrawal A, Hsu E, Quirolo K, Neumayr L, Flori H. Rate of packed red blood cell transfusion in pediatric patients with severe chronic anemia and normal cardiopulmonary status: How slow is truly necessary? Pediatric Blood and Cancer. 2010;54(6):799. [PubMed: 21793178]

Agrawal S, Davidson N, Walker M, Gibson S, Lim C, Morgan CL, et al. Assessing the total costs of blood delivery to hospital oncology and haematology patients. Current Medical Research and Opinion. 2006;22(10):1903–1909. [PubMed: 17022848]

Aguilera X, Martinez-Zapata MJ, Bosch A, Urrutia G, Gonzalez JC, Jordan M, et al. Efficacy and safety of fibrin glue and tranexamic acid to prevent postoperative blood loss in total knee arthroplasty: a randomized controlled clinical trial. Journal of Bone and Joint Surgery American Volume. 2013;95(22):2001–2007. [PubMed: 24257657]

Ahn SW, Shim JK, Youn YN, Song JW, Yang SY, Chung SC, et al. Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery. Circulation Journal. 2012;76(1):96–101. [PubMed: 22033349]

Alizadeh Ghavidel A, Totonchi Z, Chitsazan M, Gholampour Dehaki M, Jalili F, Farsad F, et al. Safety and efficacy of caproamin fides and tranexamic Acid versus placebo in patients undergoing coronary artery revascularization. Journal of Cardiovascular and Thoracic Research. 2014;6(3):197–202. [PMC free article: PMC4195972] [PubMed: 25320669]

Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). Journal of Bone and Joint Surgery American Volume. 2013;95(21):1969–1974. [PubMed: 24196467]

Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). Journal of Bone and Joint Surgery American Volume. 2013;95(21):1961–1968. [PubMed: 24196466]

Altinel L, Kaya E, Kose KC, Fidan F, Ergan V, Fidan H. Effect of shed blood retransfusion on pulmonary perfusion after total knee arthroplasty: a prospective controlled study. International Orthopaedics. 2007;31(6):837–844. [PMC free article: PMC2266671] [PubMed: 17115155]

Andreasen JJ, Nielsen C. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass. European Journal of Cardio-Thoracic Surgery. 2004;26(2):311–317. [PubMed: 15296889]

Antinolfi P, Innocenti B, Caraffa A, Peretti G, Cerulli G. Post-operative blood loss in total knee arthroplasty: knee flexion versus pharmacological techniques. Knee Surgery, Sports Traumatology, Arthroscopy. 2014;22(11):2756–2762. [PubMed: 24077690]

Armellin G, Casella S, Guzzinati S, Pasini L, Marcassa A, Giron G. Tranexamic acid in aortic valve replacement. Journal of Cardiothoracic and Vascular Anesthesia. 2001;15(3):331–335. [PubMed: 11426364]

Atay EF, Guven M, Altintas F, Kadioglu B, Ceviz E, Ipek S. Allogeneic blood transfusion decreases with postoperative autotransfusion in hip and knee arthroplasty. Acta Orthopaedica Et Traumatologica Turcica. 2010;44(4):306–312. [PubMed: 21252608]

Baric D, Biocina B, Unic D, Sutlic Z, Rudez I, Vrca VB, et al. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study. European Journal of Cardio-Thoracic Surgery. 2007;31(3):366–371. [PubMed: 17218108]

Bidolegui F, Arce G, Lugones A, Pereira S, Vindver G. Tranexamic acid reduces blood loss and transfusion in patients undergoing total knee arthroplasty without tourniquet: a prospective randomized controlled trial. Open Orthopaedics Journal. 2014;8:250–254. [PMC free article: PMC4133924] [PubMed: 25132872]

Blauhut B, Harringer W, Bettelheim P, Doran JE, Spath P, Lundsgaard-Hansen P. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery. 1994;108(6):1083–1091. [PubMed: 7527112]

Bolton-Maggs PHB, Poles D, Watt A, Thomas D. The 2013 SHOT annual report. 2014. Available from: http://www​.shotuk.org.

Bowley DM, Barker P, Boffard KD. Intraoperative blood salvage in penetrating abdominal trauma: a randomised, controlled trial. World Journal of Surgery. 2006;30(6):1074–1080. [PubMed: 16736339]

Boylan JF, Klinck JR, Sandler AN, Arellano R, Greig PD, Nierenberg H, et al. Tranexamic acid reduces blood loss, transfusion requirements, and coagulation factor use in primary orthotopic liver transplantation. Anesthesiology. 1996;85(5):1043–131A. [PubMed: 8916821]

British Committe for Standards in Haematology. Guideline on the administration of blood components. 2009. Available from: http://www​.bcshguidelines​.com/documents/Admin​_blood_components_bcsh_05012010.pdf.

Bronnum-Hansen H, Davidsen M, Thorvaldsen P. Long-term survival and causes of death after stroke. Stroke; a Journal of Cerebral Circulation. 2001;32(9):2131–2136. [PubMed: 11546907]

Bronnum-Hansen H, Jorgensen T, Davidsen M, Madsen M, Osler M, Gerdes LU, et al. Survival and cause of death after myocardial infarction: the Danish MONICA study. Journal of Clinical Epidemiology. 2001;54(12):1244–1250. [PubMed: 11750193]

Caglar GS, Tasci Y, Kayikcioglu F, Haberal A. Intravenous tranexamic acid use in myomectomy: a prospective randomized double-blind placebo controlled study. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2008;137(2):227–231. [PubMed: 17499419]

Chareancholvanich K, Siriwattanasakul P, Narkbunnam R, Pornrattanamaneewong C. Temporary clamping of drain combined with tranexamic acid reduce blood loss after total knee arthroplasty: a prospective randomized controlled trial. BMC Musculoskeletal Disorders. 2012;13:124. [PMC free article: PMC3416573] [PubMed: 22817651]

Charoencholvanich K, Siriwattanasakul P. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clinical Orthopaedics and Related Research. 2011;469(10):2874–2880. [PMC free article: PMC3171556] [PubMed: 21512813]

Coffey A, Pittmam J, Halbrook H, Fehrenbacher J, Beckman D, Hormuth D. The use of tranexamic acid to reduce postoperative bleeding following cardiac surgery: a double-blind randomized trial. American Surgeon. 1995;61(7):566–568. [PubMed: 7793735]

Commercial Medicines Unit (CMU). Electronic market information tool (EMIT). 2013. [June 2014]. Available from: http://cmu​.dh.gov.uk​/electronic-market-information-tool-emit/

Corbeau JJ, Monrigal JP, Jacob JP, Cottineau C, Moreau X, Bukowski JG, et al. Comparison of effects of aprotinin and tranexamic acid on blood loss in heart surgery. Annales Francaises D'Anesthesie Et De Reanimation. 1995;14(2):154–161. [PubMed: 7486272]

Craig J, Brown H, Eastgate J, Macpherson K, Wilson S. Understanding our advice: the use of epoetin alfa before orthopaedic surgery in patients with mild anaemia. Glasgow: NHS Quality Improvement Scotland (NHS QIS); 2006. The use of epoetin alfa before orthopaedic surgery in patients with mild anaemia. United Kingdom. Available from: http://www​.nhshealthquality.org.

Crescenti A, Borghi G, Bignami E, Bertarelli G, Landoni G, Casiraghi GM, et al. Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial. BMJ. 2011;343:d5701. [PMC free article: PMC3198510] [PubMed: 22012809]

Crotty B. Recycling blood: sharing the benefits of cell salvage. Applied Health Economics and Health Policy. 2006;5(1):5–10. [PubMed: 16774288]

Curtis L. Unit costs of health and social care 2012. Canterbury: Personal Social Services Research Unit, University of Kent; 2012. Available from: http://www​.pssru.ac.uk​/archive/pdf/uc/uc2012​/full-with-covers.pdf.

Curtis L. Unit costs of health and social care. Kent: Personal Social Services Research Unit; 2013. Available from: http://www​.pssru.ac.uk​/project-pages/unit-costs/2013/index​.php?file=full)

Dalmau A, Sabate A, Acosta F, Garcia-Huete L, Koo M, Sansano T, et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesthesia and Analgesia. 2000;91(1):29–34. [PubMed: 10866882]

Damgaard S, Steinbruchel DA. Autotransfusion with cell saver for off-pump coronary artery bypass surgery: a randomized trial. Scandinavian Cardiovascular Journal. 2006;40(3):194–198. [PubMed: 16798668]

Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: A systematic review and economic model. Health Technology Assessment. 2006;10(44):1–114. [PubMed: 17049141]

Department of Health. Reference costs 2012-2013. London: Department of Health; 2013. Available from: https://www​.gov.uk/government​/uploads/system​/uploads/attachment_data​/file/261154​/nhs_reference_costs_2012-13_acc.pdf.

Dryden PJ, O'Connor JP, Jamieson WR, Reid I, Ansley D, Sadeghi H, et al. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery. Canadian Journal of Anaesthesia. 1997;44(9):934–941. [PubMed: 9305556]

Ellis MH, Fredman B, Zohar E, Ifrach N, Jedeikin R. The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement. Journal of Clinical Anesthesia. 2001;13(7):509–513. [PubMed: 11704449]

Esfandiari BR, Bistgani MM, Kabiri M. Low dose tranexamic acid effect on post-coronary artery bypass grafting bleeding. Asian Cardiovascular and Thoracic Annals. 2013;21(6):669–674. [PubMed: 24569324]

Fergusson DA, Hebert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. New England Journal of Medicine. 2008;358(22):2319–2331. [PubMed: 18480196]

Glenngard AH, Persson U, Soderman C. Costs associated with blood transfusions in Sweden--the societal cost of autologous, allogeneic and perioperative RBC transfusion. Transfusion Medicine. 2005;15(4):295–306. [PubMed: 16101807]

Goel P, Pannu H, Mohan D, Arora R. Efficacy of cell saver in reducing homologous blood transfusions during OPCAB surgery: a prospective randomized trial. Transfusion Medicine. 2007;17(4):285–289. [PubMed: 17680954]

Goodacre S, Nicholl J, Dixon S, Cross E, Angelini K, Arnold J, et al. Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care. British Medical Journal. 2004;328(7434):254. [PMC free article: PMC324451] [PubMed: 14724129]

Haymarket Media Group. Monthly index of medical specialities. 2013. [3 June 13 A.D]. Available from: http://www​.mims.co.uk/home/

Health and Social Care Information Centre. Prescription cost analysis, England-2013. 2014. [25 September 2014]. Available from: http://www​.hscic.gov​.uk/catalogue/PUB13887.

Hiippala S, Strid L, Wennerstrand M, Arvela V, Mantyla S, Ylinen J, et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. British Journal of Anaesthesia. 1995;74(5):534–537. [PubMed: 7772427]

Hiippala ST, Strid LJ, Wennerstrand MI, Arvela JV, Niemela HM, Mantyla SK, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesthesia and Analgesia. 1997;84(4):839–844. [PubMed: 9085968]

Horrow JC, Hlavacek J, Strong MD, Collier W, Brodsky I, Goldman SM, et al. Prophylactic tranexamic acid decreases bleeding after cardiac operations. Journal of Thoracic and Cardiovascular Surgery. 1990;99(1):70–74. [PubMed: 2403616]

Horstmann WG, Swierstra MJ, Ohanis D, Rolink R, Kollen BJ, Verheyen CCPM. Favourable results of a new intraoperative and postoperative filtered autologous blood re-transfusion system in total hip arthroplasty: a randomised controlled trial. International Orthopaedics. 2014;38(1):13–18. [PMC free article: PMC3890134] [PubMed: 24077886]

Jansen AJ, Andreica S, Claeys M, D'Haese J, Camu F, Jochmans K. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. British Journal of Anaesthesia. 1999;83(4):596–601. [PubMed: 10673876]

Joint Formulary Committee. 67 British National Formulary (BNF). 63rd edition. London: British Medical Association and The Royal Pharmaceutical Society of Great Britain; 2014. Available from: http://www​.bnf.org.uk.

Karski J, Djaiani G, Carroll J, Iwanochko M, Seneviratne P, Liu P, et al. Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: a prospective randomized controlled clinical trial. Journal of Thoracic and Cardiovascular Surgery. 2005;130(2):309–314. [PubMed: 16077392]

Kaspar M, Ramsay MA, Nguyen AT, Cogswell M, Hurst G, Ramsay KJ. Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation. Anesthesia and Analgesia. 1997;85(2):281–285. [PubMed: 9249100]

Katoh J, Tsuchiya K, Sato W, Nakajima M, Iida Y. Additional postbypass administration of tranexamic acid reduces blood loss after cardiac operations. Journal of Thoracic and Cardiovascular Surgery. 1997;113(4):802–804. [PubMed: 9104995]

Katsaros D, Petricevic M, Snow NJ, Woodhall DD, Van Bergen R. Tranexamic acid reduces postbypass blood use: a double-blinded, prospective, randomized study of 210 patients. Annals of Thoracic Surgery. 1996;61(4):1131–1135. [PubMed: 8607670]

Kazemi SM, Mosaffa F, Eajazi A, Kaffashi M, Besheli LD, Bigdeli MR, et al. The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia. Orthopedics. 2010;33(1):17. [PubMed: 20055345]

Kirkos JM, Krystallis CT, Konstantinidis PA, Papavasiliou KA, Kyrkos MJ, Ikonomidis LG. Postoperative re-perfusion of drained blood in patients undergoing total knee arthroplasty: is it effective and cost-efficient? Acta Orthopaedica Belgica. 2006;72(1):18–23. [PubMed: 16570889]

Klein AA, Nashef SAM, Sharples L, Bottrill F, Dyer M, Armstrong J, et al. A randomized controlled trial of cell salvage in routine cardiac surgery. Anesthesia and Analgesia. 2008;107(5):1487–1495. [PubMed: 18931203]

Lee YC, Park SJ, Kim JS, Cho CH. Effect of tranexamic acid on reducing postoperative blood loss in combined hypotensive epidural anesthesia and general anesthesia for total hip replacement. Journal of Clinical Anesthesia. 2013;25(5):393–398. [PubMed: 23965206]

MacGillivray RG, Tarabichi SB, Hawari MF, Raoof NT. Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. Journal of Arthroplasty. 2011;26(1):24–28. [PubMed: 20171048]

MacLaren R, Sullivan PW. Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients. Value in Health. 2005;8(2):105–116. [PubMed: 15804319]

Maddali MM, Rajakumar MC. Tranexamic acid and primary coronary artery bypass surgery: a prospective study. Asian Cardiovascular and Thoracic Annals. 2007;15(4):313–319. [PubMed: 17664205]

Mansour EE, Mustafa B. Aprotinin versus tranexamic acid in patients receiving aspirin and undergoing off-pump coronary artery bypass. Egyptian Journal of Anaesthesia. 2004;20(3):229–236.

Marchetti M, Barosi G. Cost-effectiveness of epoetin and autologous blood donation in reducing allogeneic blood transfusions in coronary artery bypass graft surgery. Transfusion. 2000;40(6):673–681. [PubMed: 10864987]

Mehr-Aein A, Davoodi S, Madani-Civi M. Effects of tranexamic acid and autotransfusion in coronary artery bypass. Asian Cardiovascular and Thoracic Annals. 2007;15(1):49–53. [PubMed: 17244923]

Mercer KG, Spark JI, Berridge DC, Kent PJ, Scott DJ. Randomized clinical trial of intraoperative autotransfusion in surgery for abdominal aortic aneurysm. British Journal of Surgery. 2004;91(11):1443–1448. [PubMed: 15499651]

Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M. High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients. Anesthesia and Analgesia. 2010;110(2):350–353. [PubMed: 19996135]

Murphy GJ, Allen SM, Unsworth-White J, Lewis CT, Dalrymple-Hay MJ. Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trial. Annals of Thoracic Surgery. 2004;77(5):1553–1559. [PubMed: 15111142]

National Clinical Guideline Centre. Hypertension: The clinical management of primary hypertension in adults. London: National Institute for Clinical Excellence; 2011. Available from: http://www​.nice.org.uk​/guidance/cg127/evidence​/cg127-hypertension-full-guideline3.

National Clinical Guideline Centre. Intravenous fluid therapy in adults in hospital. London: National Clinical Guideline Centre; 2013. (NICE clinical guideline 174). Available from: http://www​.nice.org.uk​/guidance/cg174/resources​/guidance-intravenous-fluid-therapy-in-adults-in-hospital-pdf.

National Institute for Cardiovascular Outcomes Research. National adult cardiac surgery audit: annual report 2010 - 2011. London: National Institute for Cardiovascular Outcomes Research; 2011. Available from: https://www​.ucl.ac.uk​/nicor/audits/adultcardiac​/documents/reports​/annualreport2010-11.

National Institute for Health and Clinical Excellence. Social value judgements: principles for the development of NICE guidance. 2nd edition. London: National Institute for Health and Clinical Excellence; 2008. Available from: http://www​.nice.org.uk​/media/C18/30/SVJ2PUBLICATION2008.pdf. [PubMed: 27905706]

National Institute for Health and Clinical Excellence. The guidelines manual. London: National Institute for Health and Clinical Excellence; 2012. Available from: http://publications​.nice​.org.uk/the-guidelines-manual-pmg6/ [PubMed: 27905714]

National Joint Registry for England Wales and Northern Ireland. 11th Annual Report. Hemel Hempstead: National Joint Registry for England, Wales and Northern Ireland; 2014. Available from: http://www​.njrreports​.org.uk/Portals/0/PDFdownloads​/NJR%2011th​%20Annual%20Report%202014.pdf.

NHS Blood and Transplant. Price list 2013/2014. NHS Blood and Transplant; 2013.

NHS Blood and Transplant. Price list 2014/2015. NHS Blood and Transplant; 2014.

NHS Supply Chain. NHS supply chain catalogue. 2014. [20 February 2015]. Available from: http://www​.supplychain​.nhs.uk/news/company​/april-2014-national-catalogue/

Niranjan G, Asimakopoulos G, Karagounis A, Cockerill G, Thompson M, Chandrasekaran V. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial. European Journal of Cardio-Thoracic Surgery. 2006;30(2):271–277. [PubMed: 16829083]

Nuttall GA, Oliver WC, Ereth MH, Santrach PJ, Bryant SC, Orszulak TA, et al. Comparison of blood-conservation strategies in cardiac surgery patients at high risk for bleeding. Anesthesiology. 2000;92(3):674–682. [PubMed: 10719945]

Octapharma. Octaplex® product update. 2013. Available from: http://www​.rlbuht.nhs​.uk/Education%20and%20Learning​/Documents​/Emergency%20Medicine​%20App%20-%20other%20PDFs​/octaplex%20update%20V3.pdf.

Office for National Statistics. Life tables. 2011. [1 April 2011]. Available from: http://www​.ons.gov.uk​/ons/taxonomy/index​.html?nscl=Life+Tables.

Organisation for Economic Co-operation and Development (OECD). Purchasing power parities (PPP). 2013. [7 June 2012]. Available from: http://www​.oecd.org/std/ppp.

Pfizer. Prospective randomised phase IV open label comparative study of tranexamic acid plus standard care versus standard care for the reduction of blood loss in subjects undergoing surgery for long bone fracture. PhRMA Web Synopsis. 2011. Protocol B1461005.

Pleym H, Tjomsland O, Asberg A, Lydersen S, Wahba A, Bjella L, et al. Effects of autotransfusion of mediastinal shed blood on biochemical markers of myocardial damage in coronary surgery. Acta Anaesthesiologica Scandinavica. 2005;49(9):1248–1254. [PubMed: 16146460]

Rajesparan K, Biant LC, Ahmad M, Field RE. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. Journal of Bone and Joint Surgery British Volume. 2009;91(6):776–783. [PubMed: 19483232]

Research Department of Epidemiology and Public Health and UCL. 22nd annual Health Survey for England. London: Health and Social Care Information Centre; 2013. Available from: http://www​.hscic.gov​.uk/catalogue/PUB13218.

Riley W, Smalley B, Pulkrabek S, Clay ME, McCullough J. Using lean techniques to define the platelet (PLT) transfusion process and cost-effectiveness to evaluate PLT dose transfusion strategies. Transfusion. 2012;52(9):1957–1967. [PubMed: 22320153]

Sadeghi M, Mehr-Aein A. Does a single bolus dose of tranexamic acid reduce blood loss and transfusion requirements during hip fracture surgery? A prospective randomized double blind study in 67 patients. Acta Medica Iranica. 2007;45(6):437–442.

Samnaliev M, Tran CM, Sloan SR, Gasior I, Lightdale JR, Brustowicz RM. Economic evaluation of cell salvage in pediatric surgery. Paediatric Anaesthesia. 2013;23(11):1027–1034. [PubMed: 23952976]

Santos ATL, Kalil RAK, Bauemann C, Pereira JB, Nesralla IA. A randomized, double-blind, and placebo-controlled study with tranexamic acid of bleeding and fibrinolytic activity after primary coronary artery bypass grafting. Brazilian Journal of Medical and Biological Research. 2006;39(1):63–69. [PubMed: 16400465]

Seo JG, Moon YW, Park SH, Kim SM, Ko KR. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surgery, Sports Traumatology, Arthroscopy. 2013;21(8):1869–1874. [PubMed: 22729012]

Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion. 2010;50(4):753–765. [PubMed: 20003061]

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, et al. Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. JAMA Surgery. 2013;148(6):538–547. [PubMed: 23426385]

Shi J, Wang G, Lv H, Yuan S, Wang Y, Ji H, et al. Tranexamic acid in on-pump coronary artery bypass grafting without clopidogrel and aspirin cessation: randomized trial and 1-year follow-up. Annals of Thoracic Surgery. 2013;95(3):795–802. [PubMed: 22959576]

Sirvinskas E, Veikutiene A, Benetis R, Grybauskas P, Andrejaitiene J, Veikutis V, et al. Influence of early re-infusion of autologous shed mediastinal blood on clinical outcome after cardiac surgery. Perfusion. 2007;22(5):345–352. [PubMed: 18416221]

So-Osman C, Nelissen RG, Eikenboom HC, Brand A. Efficacy, safety and user-friendliness of two devices for postoperative autologous shed red blood cell re-infusion in elective orthopaedic surgery patients: A randomized pilot study. Transfusion Medicine. 2006;16(5):321–328. [PubMed: 16999754]

So-Osman C, Nelissen RGHH, Koopman-van Gemert AWMM, Kluyver E, Poll RG, Onstenk R, et al. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl. Anesthesiology. 2014;120(4):852–860. [PubMed: 24434302]

Speekenbrink RG, Vonk AB, Wildevuur CR, Eijsman L. Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting. Annals of Thoracic Surgery. 1995;59(2):438–442. [PubMed: 7531423]

Tengs TO, Lin TH. A meta-analysis of quality-of-life estimates for stroke. Pharmacoeconomics. 2003;21(3):191–200. [PubMed: 12558469]

Thomas D, Wareham K, Cohen D, Hutchings H. Autologous blood transfusion in total knee replacement surgery. British Journal of Anaesthesia. 2001;86(5):669–673. [PubMed: 11575343]

Trent Simulation & Clinical Skills Centre. Advanced autotransfusion course. 2014. [7 October 2014]. Available from: http://www​.nuh.nhs.uk​/our-services/services​/trent-simulation​/courses/advanced-autotransfusion/

Tripkovic B, Bukovic D, Sakic K, Sakic S, Bukovic N, Radakovic B. Quality of the blood sampled from surgical drainage after total hip arthroplasty. Collegium Antropologicum. 2008;32(1):153–160. [PubMed: 18494201]

Uozaki Y, Watanabe G, Kotou K, Ueyama K, Doi Y, Misaki T. Effect of tranexamic acid on blood loss reduction after cardiopulmonary bypass. Japanese Journal of Thoracic and Cardiovascular Surgery. 2001;49(5):273–278. [PubMed: 11431944]

Van Bellinghen L, De Cock E, Piedbois P. Comparing the provider time and costs for red blood cell transfusions in anaemia management of cancer patients using the activity-based costing (ABC) method in a french and autrian setting. International Society For Pharmacoeconomics And Outcomes Research. 2003;9(6):735.

Varney SJ, Guest JF. The annual cost of blood transfusions in the UK. Transfusion Medicine. 2003;13:205–218. [PubMed: 12880391]

Vermeijden WJ, Van Klarenbosch J, Gu YJ, Mariani MA, Buhre WF, Scheeren TWL, et al. Effects of cell-saving devices and filters on transfusion in cardiac surgery: A multicenter randomized study. Annals of Thoracic Surgery. 2015;99(1):26–32. [PubMed: 25440265]

Wang G, Xie G, Jiang T, Wang Y, Wang W, Ji H, et al. Tranexamic acid reduces blood loss after off-pump coronary surgery: a prospective, randomized, double-blind, placebo-controlled study. Anesthesia and Analgesia. 2012;115(2):239–243. [PubMed: 21737704]

Wei M, Jian K, Guo Z, Wang L, Jiang D, Zhang L, et al. Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass grafting. Scandinavian Cardiovascular Journal. 2006;40(2):105–109. [PubMed: 16608780]

Wilson PD, Hutchings A, Jeans A, Macdougall IC. An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic. Journal of Medical Economics. 2013;16(1):108–114. [PubMed: 22989163]

Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, et al. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. Journal of Bone and Joint Surgery American Volume. 2010;92(15):2503–2513. [PubMed: 21048170]

Xu J, Gao W, Ju Y. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial. Archives of Gynecology and Obstetrics. 2013;287(3):463–468. [PubMed: 23064441]

Yassen K, Bellamy MC, Sadek SA, Webster NR. Tranexamic acid reduces blood loss during orthotopic liver transplantation. Clinical Transplantation. 1993;7(5):453–458.

Yue C, Kang P, Yang P, Xie J, Pei F. Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. Journal of Arthroplasty. 2014;29(12):2452–2456. [PubMed: 24793893]

Zabeeda D, Medalion B, Sverdlov M, Ezra S, Schachner A, Ezri T, et al. Tranexamic acid reduces bleeding and the need for blood transfusion in primary myocardial revascularization. Annals of Thoracic Surgery. 2002;74(3):733–738. [PubMed: 12238832]

Zhao K, Xu J, Hu S, Wu Q, Wei Y, Liu Y. Autotransfusion of shed mediastinal blood after open heart surgery. Chinese Medical Journal. 2003;116(8):1179–1182. [PubMed: 12935406]

Zohar E, Ellis M, Ifrach N, Stern A, Sapir O, Fredman B. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesthesia and Analgesia. 2004;99(6):1679–1683. [PubMed: 15562053]

Zufferey PJ, Miquet M, Quenet S, Martin P, Adam P, Albaladejo P, et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. British Journal of Anaesthesia. 2010;104(1):23–30. [PubMed: 19926634]